1. • More than 50 scientific publications, 60 systematic reviews, 30 strategic literature
reviews across different therapy areas
• Modelling and simulation, data analysis for cost-effectiveness, cost-benefit, budget
impact studies for different disease scenarios, and public health interventions
• Preparation and analysis of questionnaire-based and database studies to assess the
impact of disease management
• Expertise in implementation research of public health interventions
Our
experience
includes
Capita India is the preferred partner for leading, global
pharmaceutical and healthcare companies in the areas of healthcare
research and consulting. We provide clients access to powerful,
evidence-based analyses and insights that enable them to bring new
drugs to market more quickly and effectively.
HEALTH RESEARCH
AND CONSULTING
Geographies serviced:
Set up in 2009, we have a mature health economics and outcomes research
practice, with a team of specialists providing consulting and research expertise.
Our core delivery team consists of highly qualified professionals (minimum
qualification: Masters in sciences), with vast experience in delivering a range of
services for pharmaceutical and healthcare companies, and in public health
projects.
INDIA
ASIA-PACIFIC
EUROPE
UK
US

2. HEALTH RESEARCH AND CONSULTING
Health Economics & Outcomes Research, Market Access
Our Services:
• Systematic reviews
• Strategic literature reviews
• Publications
• Internal reports
• Meta-analysis, including
Network Meta-Analysis
(NMA)
• Global value dossiers
• HTA submissions
• Bespoke communication
tools
Value Demonstration Analytics Modelling & Simulation
• Designing questionnaires
• Analysing data from data
sources and predicting
trends
• Burden of illness studies
• Quality of life analysis
• Bespoke statistics
• Cost-effectiveness
• Cost-utility
• Budget impact
• Disease modelling
• Capacity planning
Medical Communications
• Primary
manuscripts
• Review articles
• Abstracts / Posters
• Slide decks
• Other bespoke
communication
tools
• Manuscript editing
Scientific Writing Publication planning and management
• Data mining for manuscripts
• Journal selection
• Journal submission package
• Post submission support
Public Health Research
• Systematic reviews
• Strategic literature
• Reviews
• Meta-analysis
• Publications
• Internal reports
Evidence Generation Research & Analytics Health Systems
• Developing intervention /
evaluation study designs
• Quantitative & Qualitative
methods
• Analysing data from primary
and secondary data sources
• Statistical analysis
• Reports & publications
Market Research
• Drug pre-launch studies
• Analyse market size
• Market forecasting
• Market assessment for
new drugs
• Profiling companies in
select geographies
Market segmentation Insights
• Assess treatment patterns
• Analyse patient journey
• Understand patient perception
• Analyse follow-up treatment
• KOL insights on prescribing
patterns
• Assessing qualitative insights
from responder groups
• Health services research
• Health financing / health
Insurance models
• Economic evaluation
(Cost-effectiveness,
Cost-benefit, Cost-utility
analyses)
• Capacity planning

3. Some of our publications
• Mishra D, Nair SR. Systematic literature review to evaluate and characterise
the health economics and outcomes research studies in India. Perspectives in
Clinical Research 2015;6(1):20-33.
• Dror DM, Mazumdar A, Pradeep P, John D, Koren R. Implementing a
Participatory Model of Micro Health Insurance among Rural Poor, with
evidence from Nepal. Geneva Papers on Risk and Insurance - Issues and
Practice, 2014;39(2):280-303.
• Shukla H, Nair SR, Shaikh JS, Thakker D, Sharma D. Role of tele-rehabilitation
in patients following arthroplasty: Evidence from systematic literature
review. Value in Health 2014;17:A182.
• Bennett H, Sewell B, Anderson P, Rai MK, Goyal R, Phillips C.
Cost-effectiveness of interventions for chronic wound debridement: an
evaluation in search of data. Wounds UK | LDT: An economic, scientific and
clinical evaluation 2013;9(4) Suppl.
• McEwan P, Kim R, Yuan Y. Assessing the cost utility of response-guided
therapy in patients with chronic hepatitis C genotype 1 in the UK using the
MONARCH model. Appl Health Econ Health Policy 2013;11(1):53-63.
• Asche CV, Bode B, Busk AK, Nair SR. The economic and clinical benefits of
adequate insulin initiation and intensification in people with type 2 diabetes
mellitus. Diabetes, Obesity and Metabolism 2012;14(1):47-57.
• Nair SR, Rai MK, Goyal R, Shaikh JS, Pandit P, Shaikh S. HbA1C targets for
patients with type 2 diabetes: results of a systematic literature review. Value
in Health 2012;15(7):A663.
• John D, Ashton T, Nirmalan P, Parikh R. Cost-effectiveness analysis of
community screening for glaucoma in India. Value in Health 2012;
15(7):A643.
• Grzeszczak W, Czupryniak L, Kolasa K, Sciborski C, Duprat-Lomon I, McEwan
P. The cost-effectiveness of saxagliptin versus NPH insulin when used in
combination with other oral anti-diabetes agents in the treatment of type 2
diabetes mellitus in Poland. Diabetes Technology & Therapeutics 2012;14(1):
65-73.
• Erhardt W, Bergenheim K, Duprat-Lomon I, McEwan P. Cost Effectiveness of
saxagliptin and metformin versus sulfonylurea and metformin in the
treatment of type 2 diabetes mellitus in Germany. A Cardiff diabetes model
analysis. Clin Drug Investing 2012; 32 (3):1-14.
• Townsend R, McEwan P, Kim R, Yuan Y. Structural frameworks and key model
parameters in cost- effectiveness analyses for current and future treatments
of chronic hepatitis C. Value in Health 2011;1068-77.
• Nair SR. Personalised medicine: Striding from genes to medicines.
Perspectives in Clinical Research 2010;1(4):146-50.
HEALTH RESEARCH AND CONSULTING

4. Get in
touch
For more information on our Health services,
please contact:
Dr. Sunita R Nair
(Executive Committee Member-ISPOR India)
Head-Knowledge Services
Email: Sunita.Nair@capita.co.uk
Telephone: +91 98207 82340
• Application of skills and experience in devising study strategies and
planning analyses
• High quality evidence generation using well-researched, robust
methodologies
• Developing publication strategies and plan; preparing and submitting
publications
• Preparing user-friendly, branded excel-based models and other
automated study tools
• Good understanding of disease areas and advising on unmet needs
• Delivering high quality written communication tools
• Performing product detailing and market research
• Imparting learning and training
• Providing ongoing support
How we deliver value
• Team of experienced Health Economics & Outcomes Research and
Public Health professionals
• High quality of deliverables and end-to-end project management
• Swift ramp-up of projects with high volumes
• Client management, if required
• An onshore-offshore model providing price arbitrage
• Subject matter experts (SMEs) for peer-review of internal reports and
manuscripts
• Experience of delivering projects for top 10 pharmaceutical companies
The Capita India advantage: superior end-to-end
project experience
• Cardiovascular disease
• Chronic disease
• Hepatic disease
• Infectious disease
• Metabolic disorders
Disease area expertise
• Neurosciences
• Oncology
• Ophthalmology
• Renal disease
• Respiratory disease
HEALTH RESEARCH AND CONSULTING